Ionomycin ameliorates hypophosphatasia via rescuing alkaline phosphatase deficiency-mediated L-type Ca²⁺ channel internalization in mesenchymal stem cells

Abstract

The loss-of-function mutations in the ALPL result in hypophosphatasia (HPP), an inborn metabolic disorder that causes skeletal mineralization defects. In adults, the main clinical features are early loss of primary or secondary teeth, osteoporosis, bone pain, chondrocalcinosis, and fractures. However, guidelines for the treatment of adults with HPP are not available. Here, we show that ALPL deficiency caused a reduction in intracellular Ca²⁺ influx, resulting in an osteoporotic phenotype due to downregulated osteogenic differentiation and upregulated adipogenic differentiation in both human and mouse bone marrow mesenchymal stem cells (BMSCs). Increasing the intracellular level of calcium in BMSCs by ionomycin treatment rescued the osteoporotic phenotype in alpl ^+/− mice and BMSC-specific (Prrx1-alpl ^−/−) conditional alpl knockout mice. Mechanistically, ALPL was found to be required for the maintenance of intracellular Ca²⁺ influx, which it achieves by regulating L-type Ca²⁺ channel trafficking via binding to the α2δ subunits to regulate the internalization of the L-type Ca²⁺ channel. Decreased Ca²⁺ flux inactivates the Akt/GSK3β/β-catenin signaling pathway, which regulates lineage differentiation of BMSCs. This study identifies a previously unknown role of the ectoenzyme ALPL in the maintenance of calcium channel trafficking to regulate stem cell lineage differentiation and bone homeostasis. Accelerating Ca²⁺ flux through L-type Ca²⁺ channels by ionomycin treatment may be a promising therapeutic approach for adult patients with HPP.

References

[1] Millan JL, Whyte MP. Alkaline phosphatase and hypophosphatasia. Calcif. Tissue Int., 2016, 98:398-416

[2] Whyte MP. Hypophosphatasia—aetiology, nosology, pathogenesis, diagnosis and treatment. Nat. Rev. Endocrinol., 2016, 12:233-246

[3] Liu W et al. Alpl prevents bone ageing sensitivity by specifically regulating senescence and differentiation in mesenchymal stem cells. Bone Res., 2018, 6:27

[4] Li CJ et al. Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging. J. Clin. Investig., 2018, 128:5251-5266

[5] Russell RG. Excretion of inorganic pyrophosphate in hypophosphatasia. Lancet, 1965, 2:461-464

[6] Whyte MP, Mahuren JD, Vrabel LA, Coburn SP. Markedly increased circulating pyridoxal-5’-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J. Clin. Investig., 1985, 76:752-756

[7] Scheibe RJ, Kuehl H, Krautwald S, Meissner JD, Mueller WH. Ecto-alkaline phosphatase activity identified at physiological pH range on intact P19 and HL-60 cells is induced by retinoic acid. J. Cell. Biochem., 2000, 76:420-436

[8] Zimmermann H. Nucleotide signaling in nervous system development. Pflug. Arch., 2006, 452:573-588

[9] Ciancaglini P et al. Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles. J. Bone Miner. Res., 2010, 25:716-723

[10] Belachew D et al. Infantile hypophosphatasia secondary to a novel compound heterozygous mutation presenting with pyridoxine-responsive seizures. JIMD Rep., 2013, 11:17-24

[11] Barcia JP, Strife CF, Langman CB. Infantile hypophosphatasia: treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization. J. Pediatr., 1997, 130:825-828

[12] Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol., 2000, 1:11-21

[13] Cui M, Li Q, Johnson R, Fleet JC. Villin promoter-mediated transgenic expression of transient receptor potential cation channel, subfamily V, member 6 (TRPV6) increases intestinal calcium absorption in wild-type and vitamin D receptor knockout mice. J. Bone Miner. Res., 2012, 27:2097-2107

[14] Hoenderop JG et al. Renal Ca²⁺ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J. Clin. Investig., 2003, 112:1906-1914

[15] Wen L et al. L-type calcium channels play a crucial role in the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells. Biochem. Biophys. Res. Commun., 2012, 424:439-445

[16] Barradas AM et al. A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells. Biomaterials, 2012, 33:3205-3215

[17] Jung H, Best M, Akkus O. Microdamage induced calcium efflux from bone matrix activates intracellular calcium signaling in osteoblasts via L-type and T-type voltage-gated calcium channels. Bone, 2015, 76:88-96

[18] Whyte MP et al. Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J. Clin. Endocrinol. Metab., 2016, 101:334-342

[19] Whyte MP et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N. Engl. J. Med., 2012, 366:904-913

[20] Tsien RW, Lipscombe D, Madison DV, Bley KR, Fox AP. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci., 1988, 11:431-438

[21] Catterall WA. Structure and regulation of voltage-gated Ca²⁺ channels. Annu. Rev. Cell Dev. Biol., 2000, 16:521-555

[22] Praefcke GJ, McMahon HT. The dynamin superfamily: universal membrane tubulation and fission molecules? Nat. Rev. Mol. Cell Biol., 2004, 5:133-147

[23] Canti C et al. The metal-ion-dependent adhesion site in the Von Willebrand factor-A domain of alpha2delta subunits is key to trafficking voltage-gated Ca²⁺ channels. Proc. Natl Acad. Sci. USA, 2005, 102:11230-11235

[24] Tetreault MP et al. Identification of glycosylation sites essential for surface expression of the CaValpha2delta1 subunit and modulation of the cardiac CaV1.2 channel activity. J. Biol. Chem., 2016, 291:4826-4843

[25] Green EM, Barrett CF, Bultynck G, Shamah SM, Dolmetsch RE. The tumor suppressor eIF3e mediates calcium-dependent internalization of the L-type calcium channel CaV1.2. Neuron, 2007, 55:615-632

[26] Seefried L et al. Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia. J. Clin. Investig., 2017, 127:2148-2158

[27] Sun X, Kishore V, Fites K, Akkus O. Osteoblasts detect pericellular calcium concentration increase via neomycin-sensitive voltage gated calcium channels. Bone, 2012, 51:860-867

[28] Zhang J, Li M, Kang ET, Neoh KG. Electrical stimulation of adipose-derived mesenchymal stem cells in conductive scaffolds and the roles of voltage-gated ion channels. Acta Biomater., 2016, 32:46-56

[29] Snutch TP, Reiner PB. Ca²⁺ channels: diversity of form and function. Curr. Opin. Neurobiol., 1992, 2:247-253

[30] Hell JW et al. Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. J. Cell Biol., 1993, 123:949-962

[31] Ludwig A, Flockerzi V, Hofmann F. Regional expression and cellular localization of the alpha1 and beta subunit of high voltage-activated calcium channels in rat brain. J. Neurosci., 1997, 17:1339-1349

[32] Takimoto K, Li D, Nerbonne JM, Levitan ES. Distribution, splicing and glucocorticoid-induced expression of cardiac alpha 1C and alpha 1D voltage-gated Ca²⁺ channel mRNAs. J. Mol. Cell. Cardiol., 1997, 29:3035-3042

[33] Foster BL et al. Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J. Bone Miner. Res., 2013, 28:271-282

[34] Foster BL et al. Rare bone diseases and their dental, oral, and craniofacial manifestations. J. Dent. Res., 2014, 93:7S-19S

[35] Waymire KG et al. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat. Genet., 1995, 11:45-51

[36] Narisawa S, Frohlander N, Millan JL. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev. Dyn., 1997, 208:432-446

[37] Foster BL et al. Conditional alpl ablation phenocopies dental defects of hypophosphatasia. J. Dent. Res., 2017, 96:81-91

[38] Ambrosi TH et al. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem Cell, 2017, 20:771-784 e776

[39] Liu Y et al. Hydrogen sulfide maintains mesenchymal stem cell function and bone homeostasis via regulation of Ca(2+) channel sulfhydration. Cell Stem Cell, 2014, 15:66-78

[40] Merritt JE, McCarthy SA, Davies MP, Moores KE. Use of fluo-3 to measure cytosolic Ca²⁺ in platelets and neutrophils. Loading cells with the dye, calibration of traces, measurements in the presence of plasma, and buffering of cytosolic Ca²⁺. Biochem J., 1990, 269:513-519

[41] Jin OU et al. Interaction of alpha1-adrenoceptor subtypes with different G proteins induces opposite effects on cardiac L-type Ca²⁺ channel. Circ. Res., 2008, 102:1378-1388

[42] Moffat J et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell, 2006, 124:1283-1298

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81620108007)